Sign In
Buy CRVS
$11.60
-0.0900 (-0.770%)
At Close: Jun 03, 2026
Updated interim d ata from CPI-818 's p hase 1/1b c linical t rial provide evidence supporting its potential as a treatment for T cell lymphomas
Corvus Announces Upcoming CPI-818 Data Presentations at the American Society of Hematology (ASH) Annual Meeting & Exposition
08:00am, Monday, 30'th Nov 2020
Includes updated data from CPI-818 phase 1/1b trial and pre-clinical results supporting use in autoimmune lymphoproliferative syndrome (ALPS) Includes updated data from CPI-818 phase 1/1b trial and pr
Corvus Hosting R&D Symposium on November 12 to Highlight COVID-19 Program and Updated Study Data Presented at SITC Annual Meeting
04:05pm, Wednesday, 11'th Nov 2020
Data shows CPI-006 provide d enhanced and prolonged polyclonal humoral immunity to SARS - CoV - 2
Data to be presented in a poster and an oral session “ Hot Topic Symposium : COVID-19 and Cancer ” at SITC
Company to host R&D Symposium webcast November 12, 2020 at 11:00 am ET to highlight COVID-19 program and provide updates on its cancer programs Company to host R&D Symposium webcast November 12, 2020
The
Corvus Pharmaceuticals to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
08:05pm, Tuesday, 04'th Aug 2020
BURLINGAME, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that it will present at the 2020 Wedbush
How Much Of Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Do Insiders Own?
03:33pm, Monday, 03'rd Aug 2020
The big shareholder groups in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) have power over the company. Generally...
The Daily Biotech Pulse: Sanofi-GSK Land $2.1B Funding For Coronavirus Vaccine, D-Day For GW Pharma, FDA Nod For Roche
12:00am, Friday, 31'st Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 30)
Achieve Life Sciences Inc (NASDAQ: ACHV)
Annexon Inc (NASDAQ: ANNX) (IPOed July 24)
Atossa Therapeutics...
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial Results
08:02pm, Thursday, 30'th Jul 2020
Provides Update on CPI-006 Phase 1 COVID-19 Study Conference Call Today at 4:30 p.m. ET / 1:30 p.m. PT BURLINGAME, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 29)
Abbott Laboratories (NYSE: ABT)
ABIOMED, Inc. (NASDAQ: ABMD)
Adamis Pharmaceuticals Corp (NASDAQ: ADMP)
Annexon...
Corvus Pharmaceuticals to Provide Business Update and Report Second Quarter 2020 Financial Results on July 30, 2020
12:30pm, Thursday, 23'rd Jul 2020
Company to host conference call and webcast at 4:30 pm ET / 1:30 pm PTBURLINGAME, Calif., July 23, 2020 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceuti
IPO Update: iTeos Therapeutics Finalizes IPO Plan
01:31pm, Tuesday, 21'st Jul 2020
iTeos Therapeutics has filed to raise $151 million from an IPO of its common stock. The firm is developing treatments for solid tumors and other high prevalence cancer conditions.
3 “Strong Buy” Healthcare Stocks Under $5 That Could Double (Or More)
07:30pm, Monday, 20'th Jul 2020
The healthcare sector took its place among the winners this year, rising 21%, compared to the S&P 500’s 0.5% growth. The bottom-line for investors? Wall Street’s focus is on the healthcare space,
